GUESLINE EUGENE: Open Payments
NPI 1033849732 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,048 in 43 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,048
Food & beverage: $1,044Education: $4
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 5 | $271 |
| ABBVIE INC. | 7 | $154 |
| Janssen Biotech, Inc. | 6 | $123 |
| Novartis Pharmaceuticals Corporation | 6 | $108 |
| UCB, Inc. | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| PFIZER INC. | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $22 |
Products named: Korlym, TREMFYA, LEQVIO, RINVOQ, Bimzelx, SKYRIZI, SAPHNELO, Kerendia.
Industry payments across FL — which companies pay providers there.
